Back to Search
Start Over
Midterm results of endovascular treatment of atherosclerotic aneurysms of the descending thoracic aorta.
- Source :
- Journal of Thoracic & Cardiovascular Surgery; Nov2006, Vol. 132 Issue 5, p1030-1036, 7p
- Publication Year :
- 2006
-
Abstract
- Objective: We sought to determine the midterm results of endovascular repair of atherosclerotic aneurysms of the thoracic descending aorta by using second-generation, commercially available stent grafts. Methods: Between 1996 and 2005, 45 patients (mean age, 68 ± 11 years) with aneurysms of the descending thoracic aorta underwent endovascular repair. Aortic dissections, penetrating ulcers, and traumatisms were excluded. The mean follow-up was 24.7 ± 21.6 months (maximum, 6.7 years). Results: No patients died, and no conversion to surgical intervention was required during the procedures. Three (6.7%) patients died during the first month, and 6 (14.7%) died later on. The main complications were strokes (13.3%), vascular access complications (8.9%), aortic complications (6.6%), paraplegia (4.4%), and sudden deaths (4.4%). Nineteen (42%) primary endoleaks were encountered: 3 required reinterventions, 15 spontaneously thrombosed, and 1 patient died. Except for 2 sudden unexplained deaths, no aortic complications were observed after 1 month. Actuarial survival estimates at 1, 3, and 5 years were 87.6% ± 5.3%, 76.9% ± 7.4%, and 70.6% ± 9.2%, respectively. Actuarial freedom from death related to the treated aortic disease was 94.3% ± 4.0%, 94.3% ± 4.0%, and 86.4% ± 8.4% at 1, 3, and 5 years, respectively. Aspirin status of greater than 3 (P = .005), high aortic diameter (P = .007), and long covered lengths (P = .02) were determinant for mortality. Actuarial freedom from complication was 62.6% ± 7.7%, 58.9% ± 8.1%, and 58.9% ± 8.1% at 1, 3, and 5 years, respectively. The location of the aneurysm (P = .05) and a high aortic diameter (P = .04) were both determinants for endoleaks. Conclusions: Stent grafting of atherosclerotic aneurysm of the thoracic descending aorta is safe and effective. Further studies are mandatory to determine the most relevant indications and the long-term efficacy of such treatment. [Copyright &y& Elsevier]
- Subjects :
- VASCULAR diseases
ANEURYSMS
TRAUMATISM
NONSTEROIDAL anti-inflammatory agents
Subjects
Details
- Language :
- English
- ISSN :
- 00225223
- Volume :
- 132
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- Journal of Thoracic & Cardiovascular Surgery
- Publication Type :
- Academic Journal
- Accession number :
- 22840494
- Full Text :
- https://doi.org/10.1016/j.jtcvs.2006.07.006